AstraZeneca Pharma India Reports 32% Profit Decline in Q1 Amid Higher Expenses
AstraZeneca Pharma India Ltd reported a 32% decline in profit after tax to Rs 37.93 crore for the June quarter, down from Rs 55.83 crore in the same period last year. Revenue increased to Rs 682.79 crore from Rs 526.31 crore, while total expenses rose to Rs 641.03 crore from Rs 462.49 crore. The company highlighted portfolio strengthening through regulatory approvals and strategic partnerships aimed at expanding patient access in India, according to Country President Praveen Rao Akkinepally.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 36/100.
Outlets measured: businessstandard, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 10 Aug, 09:17 am. Other outlets followed.
- 1